ArticleDiabetes, obesity & metabolism2020

Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes.

Alexandra Coomans de Brachène et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.